In a compelling Genomic Press Interview published in Brain Medicine on September 25, 2024, Professor Hermona Soreq of the ...

Altamira Therapeutics Ltd (CYTO) reports significant progress in RNA delivery programs and financial restructuring.

Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.

Moderna (MRNA) closed at $63.94 in the latest trading session, marking a -0.31% move from the prior day. This change lagged the S&P 500's 0.25% gain on the day. At the same time, the Dow added 0.2%, ...

Shares of Moderna Inc. MRNA dropped 0.31% to $63.94 Tuesday, on what proved to be an all-around favorable trading session for ...

As levels of the coronavirus have increased in Missouri and across the country, the federal government has approved updated vaccines to protect against COVID-19. The virus itself has changed, and ...

Projects focus on cancer therapies, robotic clot removal catheters, and mRNA vaccines, among other technologies ...

Buying $100 In MRNA: If an investor had bought $100 of MRNA stock 5 years ago, it would be worth $406.92 today based on a ...

A prominent Florida doctor expressed dismay that medical leaders in the state, leery of angering Gov. Ron DeSantis, have been ...

Good morning, and welcome to the Altamira Therapeutics First Half 2024 and Business Update Conference Call. On today's call are Thomas Meyer, Altamira's Founder, Chairman and Chief Executive Officer; ...

The new Pfizer and Moderna mRNA vaccines against COVID were approved in August. Vaccinations are now widely available.

Pfizer Canada says Health Canada has approved its updated COVID-19 vaccine that protects against one of the most recently ...